Jürgen Schanzer
MorphoSys (Germany)(DE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, CAR-T cell therapy research, Angiogenesis and VEGF in Cancer, HIV Research and Treatment
Most-Cited Works
- → Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies(2011)462 cited
- → Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies(2012)199 cited
- → Design, Synthesis, and Characterization of a Series of Cytochrome P4503A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver§(2004)157 cited
- → Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains(2011)62 cited
- → TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations(2016)27 cited
- → Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2(2016)22 cited
- → CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS(2023)19 cited
- → Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro(2020)9 cited
- → Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma(2023)6 cited
- → The Impact of Prior Treatment with a CD19 Targeting Monoclonal Antibody on Subsequent Treatment with CD19 Targeting CART Cell Therapy in Preclinical Models(2022)1 cited